Physician profile
Patrick Frances Del Vecchio
NPI 1538158357
$3,703.46
in general payments reported to CMS, 2019-2025
18 companies · $898 in 2025
The $898 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $127 · 2021: $341 · 2022: $496 · 2023: $267 · 2024: $1,074 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,238.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $435.00 | 2023-2025 | Infuse, Miebo |
| Oyster Point Pharma, INC. | $406.49 | 2022-2025 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $406.15 | 2024-2025 | Xdemvy |
| Coopervision INC. | $396.78 | 2020-2025 | Misight Contact Lens |
| Biotissue Holdings INC. | $378.09 | 2022-2024 | |
| Dompe US, INC. | $376.55 | 2024-2025 | Oxervate |
| Alcon Vision LLC | $372.12 | 2019-2025 | Total30, Tryptyr, Dailies Total1 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $238.69 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $216.81 | 2019-2023 | Acuvue |
| Allergan, INC. | $109.08 | 2019-2022 | |
| Optos, INC. | $96.78 | 2019 | |
| Abbvie INC. | $58.66 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $49.93 | 2024 | Cirrus Hd-Oct |
| Kala Pharmaceuticals, INC. | $49.90 | 2021 | |
| Visioneering Technologies, INC. | $40.34 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $35.00 | 2019-2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Novartis Pharmaceuticals Corporation | $17.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Del Vecchio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.